PDB Short entry for 4IVE HEADER RNA BINDING PROTEIN 22-JAN-13 4IVE TITLE CRYSTAL STRUCTURE OF A POLYADENYLATE-BINDING PROTEIN 3 (PABPC3) FROM TITLE 2 HOMO SAPIENS AT 2.30 A RESOLUTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: POLYADENYLATE-BINDING PROTEIN 3; COMPND 3 CHAIN: A, B, C, D; COMPND 4 FRAGMENT: PABC DOMAIN RESIDUES 535-631; COMPND 5 SYNONYM: PABP-3, POLY(A)-BINDING PROTEIN 3, TESTIS-SPECIFIC POLY(A)- COMPND 6 BINDING PROTEIN; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BC027617, PABP3, PABPC3, PABPL3; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: PB1; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: SPEEDET KEYWDS PABP UNIQUE DOMAIN, PF00658 FAMILY, STRUCTURAL GENOMICS, JOINT CENTER KEYWDS 2 FOR STRUCTURAL GENOMICS, JCSG, PROTEIN STRUCTURE INITIATIVE, PSI- KEYWDS 3 BIOLOGY, RNA-BINDING PROTEIN, RNA BINDING PROTEIN, PARTNERSHIP FOR KEYWDS 4 T-CELL BIOLOGY, TCELL EXPDTA X-RAY DIFFRACTION AUTHOR JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG),PARTNERSHIP FOR T-CELL AUTHOR 2 BIOLOGY (TCELL) REVDAT 3 01-FEB-23 4IVE 1 REMARK SEQADV LINK REVDAT 2 15-NOV-17 4IVE 1 REMARK REVDAT 1 06-FEB-13 4IVE 0 JRNL AUTH JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG), JRNL AUTH 2 PARTNERSHIP FOR T-CELL BIOLOGY (TCELL) JRNL TITL CRYSTAL STRUCTURE OF A POLYADENYLATE-BINDING PROTEIN 3 JRNL TITL 2 (PABPC3) FROM HOMO SAPIENS AT 2.30 A RESOLUTION JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER-TNT 2.10.0 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SMART,VONRHEIN,WOMACK, REMARK 3 : MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 43.13 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 3 NUMBER OF REFLECTIONS : 20056 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.201 REMARK 3 R VALUE (WORKING SET) : 0.201 REMARK 3 FREE R VALUE : 0.212 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.070 REMARK 3 FREE R VALUE TEST SET COUNT : 1016 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 10 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.42 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.58 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2879 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2015 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2747 REMARK 3 BIN R VALUE (WORKING SET) : 0.1995 REMARK 3 BIN FREE R VALUE : 0.2442 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.58 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 132 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2310 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 2 REMARK 3 SOLVENT ATOMS : 133 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 47.54 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 56.66 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -5.04640 REMARK 3 B22 (A**2) : -5.04640 REMARK 3 B33 (A**2) : 10.09270 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.357 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.928 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.928 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2422 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 3292 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1208 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 63 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 354 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2422 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 334 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 2964 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.05 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.18 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 2.67 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 4 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: {A|537 - 612} REMARK 3 ORIGIN FOR THE GROUP (A): 32.5961 5.2067 34.9959 REMARK 3 T TENSOR REMARK 3 T11: -0.1722 T22: -0.0079 REMARK 3 T33: -0.1571 T12: 0.0411 REMARK 3 T13: 0.0436 T23: 0.0104 REMARK 3 L TENSOR REMARK 3 L11: 5.2051 L22: 2.7463 REMARK 3 L33: 8.3043 L12: -0.5073 REMARK 3 L13: -2.9104 L23: 1.7077 REMARK 3 S TENSOR REMARK 3 S11: -0.1195 S12: 0.4790 S13: -0.0245 REMARK 3 S21: 0.0176 S22: 0.0914 S23: 0.2472 REMARK 3 S31: -0.0230 S32: -0.4441 S33: 0.0281 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: {B|538 - 614} REMARK 3 ORIGIN FOR THE GROUP (A): 14.0336 10.1033 40.7462 REMARK 3 T TENSOR REMARK 3 T11: -0.2594 T22: 0.1354 REMARK 3 T33: -0.1581 T12: 0.1520 REMARK 3 T13: -0.0471 T23: -0.0262 REMARK 3 L TENSOR REMARK 3 L11: 4.5334 L22: 2.0930 REMARK 3 L33: 8.3155 L12: -0.1746 REMARK 3 L13: -1.3191 L23: 1.3940 REMARK 3 S TENSOR REMARK 3 S11: 0.1601 S12: 0.5442 S13: 0.2683 REMARK 3 S21: -0.2480 S22: -0.3809 S23: 0.2485 REMARK 3 S31: -0.4700 S32: -0.5442 S33: 0.2208 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 SELECTION: {C|538 - 613} REMARK 3 ORIGIN FOR THE GROUP (A): 12.4094 14.5409 67.0452 REMARK 3 T TENSOR REMARK 3 T11: -0.1353 T22: -0.1298 REMARK 3 T33: -0.1187 T12: 0.0207 REMARK 3 T13: 0.0392 T23: -0.0395 REMARK 3 L TENSOR REMARK 3 L11: 4.8886 L22: 7.5299 REMARK 3 L33: 4.2650 L12: -2.6500 REMARK 3 L13: -0.6239 L23: -0.0312 REMARK 3 S TENSOR REMARK 3 S11: -0.0234 S12: -0.0686 S13: -0.5442 REMARK 3 S21: 0.5297 S22: -0.1305 S23: 0.4828 REMARK 3 S31: -0.1313 S32: -0.2367 S33: 0.1540 REMARK 3 REMARK 3 TLS GROUP : 4 REMARK 3 SELECTION: {D|538 - 613} REMARK 3 ORIGIN FOR THE GROUP (A): 27.6101 2.7740 61.1619 REMARK 3 T TENSOR REMARK 3 T11: -0.1614 T22: -0.0136 REMARK 3 T33: -0.0624 T12: 0.0313 REMARK 3 T13: 0.0315 T23: 0.0475 REMARK 3 L TENSOR REMARK 3 L11: 1.7851 L22: 2.7042 REMARK 3 L33: 8.3155 L12: -0.8429 REMARK 3 L13: 0.1631 L23: -1.7318 REMARK 3 S TENSOR REMARK 3 S11: -0.0432 S12: -0.0238 S13: -0.0661 REMARK 3 S21: -0.0481 S22: -0.3216 S23: -0.2696 REMARK 3 S31: 0.2565 S32: 0.5148 S33: 0.3648 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: 1. ATOM RECORD CONTAINS SUM OF TLS AND REMARK 3 RESIDUAL B FACTORS. ANISOU RECORD CONTAINS SUM OF TLS AND REMARK 3 RESIDUAL U FACTORS. 2. CHLORIDE IONS MODELED ARE PRESENT IN REMARK 3 CRYSTALLIZATION BUFFER. 3. A MET-INHIBITION PROTOCOL WAS USED REMARK 3 FOR SELENOMETHIONINE INCORPORATION DURING PROTEIN EXPRESSION. REMARK 3 THE OCCUPANCY OF THE SE ATOMS IN THE MSE RESIDUES WAS REDUCED TO REMARK 3 0.75 FOR THE REDUCED SCATTERING POWER DUE TO PARTIAL S-MET REMARK 3 INCORPORATION. 4. THE MAD PHASES WERE USED AS RESTRAINTS DURING REMARK 3 REFINEMENT. 5. NCS RESTRAINTS WERE APPLIED USING BUSTER'S LSSR REMARK 3 RESTRAINT REPRESENTATION (-AUTONCS). REMARK 4 REMARK 4 4IVE COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 25-JAN-13. REMARK 100 THE DEPOSITION ID IS D_1000077257. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 17-OCT-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.62 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 8.2.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.979493,0.918401,0.979284 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL SI(111) REMARK 200 OPTICS : KOHZU: DOUBLE CRYSTAL SI(111) REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE MARCH 15, 2012 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 20106 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 43.128 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.09700 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 12.0300 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.38 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.8 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.75600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: MAD REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: SHELX, SHARP, SHELXD REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.23 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.69 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 26.00% POLYETHYLENE GLYCOL 6000, 0.1M REMARK 280 MES PH 5.62, NANODROP, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y,X,Z+3/4 REMARK 290 4555 Y,-X,Z+1/4 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 50.69000 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 76.03500 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 25.34500 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4, 5, 6, 7 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5510 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 14880 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -40.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1710 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 8490 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -15.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1710 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 8470 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -15.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 5 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 6 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 7 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 0 REMARK 465 GLN A 535 REMARK 465 GLY A 536 REMARK 465 GLN A 613 REMARK 465 ALA A 614 REMARK 465 LYS A 615 REMARK 465 GLU A 616 REMARK 465 ALA A 617 REMARK 465 THR A 618 REMARK 465 GLN A 619 REMARK 465 LYS A 620 REMARK 465 ALA A 621 REMARK 465 VAL A 622 REMARK 465 ASN A 623 REMARK 465 SER A 624 REMARK 465 ALA A 625 REMARK 465 THR A 626 REMARK 465 GLY A 627 REMARK 465 VAL A 628 REMARK 465 PRO A 629 REMARK 465 THR A 630 REMARK 465 VAL A 631 REMARK 465 GLY B 0 REMARK 465 GLN B 535 REMARK 465 GLY B 536 REMARK 465 GLN B 537 REMARK 465 LYS B 615 REMARK 465 GLU B 616 REMARK 465 ALA B 617 REMARK 465 THR B 618 REMARK 465 GLN B 619 REMARK 465 LYS B 620 REMARK 465 ALA B 621 REMARK 465 VAL B 622 REMARK 465 ASN B 623 REMARK 465 SER B 624 REMARK 465 ALA B 625 REMARK 465 THR B 626 REMARK 465 GLY B 627 REMARK 465 VAL B 628 REMARK 465 PRO B 629 REMARK 465 THR B 630 REMARK 465 VAL B 631 REMARK 465 GLY C 0 REMARK 465 GLN C 535 REMARK 465 GLY C 536 REMARK 465 GLN C 537 REMARK 465 ALA C 614 REMARK 465 LYS C 615 REMARK 465 GLU C 616 REMARK 465 ALA C 617 REMARK 465 THR C 618 REMARK 465 GLN C 619 REMARK 465 LYS C 620 REMARK 465 ALA C 621 REMARK 465 VAL C 622 REMARK 465 ASN C 623 REMARK 465 SER C 624 REMARK 465 ALA C 625 REMARK 465 THR C 626 REMARK 465 GLY C 627 REMARK 465 VAL C 628 REMARK 465 PRO C 629 REMARK 465 THR C 630 REMARK 465 VAL C 631 REMARK 465 GLY D 0 REMARK 465 GLN D 535 REMARK 465 GLY D 536 REMARK 465 GLN D 537 REMARK 465 ALA D 614 REMARK 465 LYS D 615 REMARK 465 GLU D 616 REMARK 465 ALA D 617 REMARK 465 THR D 618 REMARK 465 GLN D 619 REMARK 465 LYS D 620 REMARK 465 ALA D 621 REMARK 465 VAL D 622 REMARK 465 ASN D 623 REMARK 465 SER D 624 REMARK 465 ALA D 625 REMARK 465 THR D 626 REMARK 465 GLY D 627 REMARK 465 VAL D 628 REMARK 465 PRO D 629 REMARK 465 THR D 630 REMARK 465 VAL D 631 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 HIS A 612 CG ND1 CD2 CE1 NE2 REMARK 470 GLU B 538 CG CD OE1 OE2 REMARK 470 GLN B 613 CG CD OE1 NE2 REMARK 470 GLU C 538 CG CD OE1 OE2 REMARK 470 ARG C 544 CG CD NE CZ NH1 NH2 REMARK 470 GLN C 613 CG CD OE1 NE2 REMARK 470 GLU D 538 CG CD OE1 OE2 REMARK 470 GLN D 613 CG CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR B 571 -84.96 -60.18 REMARK 500 LEU B 572 42.72 -98.79 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 701 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL C 701 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: JCSG-424003 RELATED DB: TARGETTRACK REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE CONSTRUCT (535-631) WAS EXPRESSED WITH A PURIFICATION TAG REMARK 999 MGSDKIHHHHHHENLYFQG. THE TAG WAS REMOVED WITH TEV PROTEASE LEAVING REMARK 999 ONLY A GLYCINE (0) FOLLOWED BY THE TARGET SEQUENCE. DBREF 4IVE A 535 631 UNP Q9H361 PABP3_HUMAN 535 631 DBREF 4IVE B 535 631 UNP Q9H361 PABP3_HUMAN 535 631 DBREF 4IVE C 535 631 UNP Q9H361 PABP3_HUMAN 535 631 DBREF 4IVE D 535 631 UNP Q9H361 PABP3_HUMAN 535 631 SEQADV 4IVE GLY A 0 UNP Q9H361 EXPRESSION TAG SEQADV 4IVE GLY B 0 UNP Q9H361 EXPRESSION TAG SEQADV 4IVE GLY C 0 UNP Q9H361 EXPRESSION TAG SEQADV 4IVE GLY D 0 UNP Q9H361 EXPRESSION TAG SEQRES 1 A 98 GLY GLN GLY GLN GLU THR LEU THR ALA SER ARG LEU ALA SEQRES 2 A 98 SER ALA PRO PRO GLN LYS GLN LYS GLN MSE LEU GLY GLU SEQRES 3 A 98 ARG LEU PHE PRO LEU ILE GLN ALA MSE HIS PRO THR LEU SEQRES 4 A 98 ALA GLY LYS ILE THR GLY MSE LEU LEU GLU ILE ASP ASN SEQRES 5 A 98 SER GLU LEU LEU TYR MSE LEU GLU SER PRO GLU SER LEU SEQRES 6 A 98 ARG SER LYS VAL ASP GLU ALA VAL ALA VAL LEU GLN ALA SEQRES 7 A 98 HIS GLN ALA LYS GLU ALA THR GLN LYS ALA VAL ASN SER SEQRES 8 A 98 ALA THR GLY VAL PRO THR VAL SEQRES 1 B 98 GLY GLN GLY GLN GLU THR LEU THR ALA SER ARG LEU ALA SEQRES 2 B 98 SER ALA PRO PRO GLN LYS GLN LYS GLN MSE LEU GLY GLU SEQRES 3 B 98 ARG LEU PHE PRO LEU ILE GLN ALA MSE HIS PRO THR LEU SEQRES 4 B 98 ALA GLY LYS ILE THR GLY MSE LEU LEU GLU ILE ASP ASN SEQRES 5 B 98 SER GLU LEU LEU TYR MSE LEU GLU SER PRO GLU SER LEU SEQRES 6 B 98 ARG SER LYS VAL ASP GLU ALA VAL ALA VAL LEU GLN ALA SEQRES 7 B 98 HIS GLN ALA LYS GLU ALA THR GLN LYS ALA VAL ASN SER SEQRES 8 B 98 ALA THR GLY VAL PRO THR VAL SEQRES 1 C 98 GLY GLN GLY GLN GLU THR LEU THR ALA SER ARG LEU ALA SEQRES 2 C 98 SER ALA PRO PRO GLN LYS GLN LYS GLN MSE LEU GLY GLU SEQRES 3 C 98 ARG LEU PHE PRO LEU ILE GLN ALA MSE HIS PRO THR LEU SEQRES 4 C 98 ALA GLY LYS ILE THR GLY MSE LEU LEU GLU ILE ASP ASN SEQRES 5 C 98 SER GLU LEU LEU TYR MSE LEU GLU SER PRO GLU SER LEU SEQRES 6 C 98 ARG SER LYS VAL ASP GLU ALA VAL ALA VAL LEU GLN ALA SEQRES 7 C 98 HIS GLN ALA LYS GLU ALA THR GLN LYS ALA VAL ASN SER SEQRES 8 C 98 ALA THR GLY VAL PRO THR VAL SEQRES 1 D 98 GLY GLN GLY GLN GLU THR LEU THR ALA SER ARG LEU ALA SEQRES 2 D 98 SER ALA PRO PRO GLN LYS GLN LYS GLN MSE LEU GLY GLU SEQRES 3 D 98 ARG LEU PHE PRO LEU ILE GLN ALA MSE HIS PRO THR LEU SEQRES 4 D 98 ALA GLY LYS ILE THR GLY MSE LEU LEU GLU ILE ASP ASN SEQRES 5 D 98 SER GLU LEU LEU TYR MSE LEU GLU SER PRO GLU SER LEU SEQRES 6 D 98 ARG SER LYS VAL ASP GLU ALA VAL ALA VAL LEU GLN ALA SEQRES 7 D 98 HIS GLN ALA LYS GLU ALA THR GLN LYS ALA VAL ASN SER SEQRES 8 D 98 ALA THR GLY VAL PRO THR VAL MODRES 4IVE MSE A 556 MET SELENOMETHIONINE MODRES 4IVE MSE A 568 MET SELENOMETHIONINE MODRES 4IVE MSE A 579 MET SELENOMETHIONINE MODRES 4IVE MSE A 591 MET SELENOMETHIONINE MODRES 4IVE MSE B 556 MET SELENOMETHIONINE MODRES 4IVE MSE B 568 MET SELENOMETHIONINE MODRES 4IVE MSE B 579 MET SELENOMETHIONINE MODRES 4IVE MSE B 591 MET SELENOMETHIONINE MODRES 4IVE MSE C 556 MET SELENOMETHIONINE MODRES 4IVE MSE C 568 MET SELENOMETHIONINE MODRES 4IVE MSE C 579 MET SELENOMETHIONINE MODRES 4IVE MSE C 591 MET SELENOMETHIONINE MODRES 4IVE MSE D 556 MET SELENOMETHIONINE MODRES 4IVE MSE D 568 MET SELENOMETHIONINE MODRES 4IVE MSE D 579 MET SELENOMETHIONINE MODRES 4IVE MSE D 591 MET SELENOMETHIONINE HET MSE A 556 8 HET MSE A 568 8 HET MSE A 579 13 HET MSE A 591 13 HET MSE B 556 8 HET MSE B 568 8 HET MSE B 579 13 HET MSE B 591 13 HET MSE C 556 8 HET MSE C 568 8 HET MSE C 579 8 HET MSE C 591 13 HET MSE D 556 8 HET MSE D 568 8 HET MSE D 579 8 HET MSE D 591 13 HET CL A 701 1 HET CL C 701 1 HETNAM MSE SELENOMETHIONINE HETNAM CL CHLORIDE ION FORMUL 1 MSE 16(C5 H11 N O2 SE) FORMUL 5 CL 2(CL 1-) FORMUL 7 HOH *133(H2 O) HELIX 1 1 THR A 541 SER A 547 1 7 HELIX 2 2 PRO A 549 HIS A 569 1 21 HELIX 3 3 LEU A 572 LEU A 581 1 10 HELIX 4 4 ASP A 584 GLU A 593 1 10 HELIX 5 5 SER A 594 GLN A 610 1 17 HELIX 6 6 THR B 541 ALA B 548 1 8 HELIX 7 7 PRO B 549 GLN B 551 5 3 HELIX 8 8 LYS B 552 HIS B 569 1 18 HELIX 9 9 LEU B 572 LEU B 581 1 10 HELIX 10 10 ASP B 584 SER B 594 1 11 HELIX 11 11 SER B 594 GLN B 610 1 17 HELIX 12 12 THR C 541 SER C 547 1 7 HELIX 13 13 PRO C 549 HIS C 569 1 21 HELIX 14 14 LEU C 572 LEU C 581 1 10 HELIX 15 15 ASP C 584 LEU C 592 1 9 HELIX 16 16 SER C 594 GLN C 610 1 17 HELIX 17 17 THR D 541 ALA D 548 1 8 HELIX 18 18 PRO D 549 GLN D 551 5 3 HELIX 19 19 LYS D 552 ALA D 567 1 16 HELIX 20 20 LEU D 572 LEU D 581 1 10 HELIX 21 21 ASP D 584 SER D 594 1 11 HELIX 22 22 SER D 594 GLN D 610 1 17 LINK C GLN A 555 N MSE A 556 1555 1555 1.35 LINK C MSE A 556 N LEU A 557 1555 1555 1.33 LINK C ALA A 567 N MSE A 568 1555 1555 1.36 LINK C MSE A 568 N HIS A 569 1555 1555 1.34 LINK C GLY A 578 N MSE A 579 1555 1555 1.35 LINK C MSE A 579 N LEU A 580 1555 1555 1.35 LINK C TYR A 590 N MSE A 591 1555 1555 1.35 LINK C MSE A 591 N LEU A 592 1555 1555 1.35 LINK C GLN B 555 N MSE B 556 1555 1555 1.35 LINK C MSE B 556 N LEU B 557 1555 1555 1.34 LINK C ALA B 567 N MSE B 568 1555 1555 1.35 LINK C MSE B 568 N HIS B 569 1555 1555 1.35 LINK C GLY B 578 N MSE B 579 1555 1555 1.36 LINK C MSE B 579 N LEU B 580 1555 1555 1.36 LINK C TYR B 590 N MSE B 591 1555 1555 1.35 LINK C MSE B 591 N LEU B 592 1555 1555 1.35 LINK C GLN C 555 N MSE C 556 1555 1555 1.35 LINK C MSE C 556 N LEU C 557 1555 1555 1.33 LINK C ALA C 567 N MSE C 568 1555 1555 1.34 LINK C MSE C 568 N HIS C 569 1555 1555 1.35 LINK C GLY C 578 N MSE C 579 1555 1555 1.34 LINK C MSE C 579 N LEU C 580 1555 1555 1.36 LINK C TYR C 590 N MSE C 591 1555 1555 1.35 LINK C MSE C 591 N LEU C 592 1555 1555 1.34 LINK C GLN D 555 N MSE D 556 1555 1555 1.35 LINK C MSE D 556 N LEU D 557 1555 1555 1.34 LINK C ALA D 567 N MSE D 568 1555 1555 1.33 LINK C MSE D 568 N HIS D 569 1555 1555 1.35 LINK C GLY D 578 N MSE D 579 1555 1555 1.34 LINK C MSE D 579 N LEU D 580 1555 1555 1.36 LINK C TYR D 590 N MSE D 591 1555 1555 1.35 LINK C MSE D 591 N LEU D 592 1555 1555 1.35 SITE 1 AC1 2 HIS A 569 THR A 571 SITE 1 AC2 3 HIS C 569 PRO C 570 THR C 571 CRYST1 67.395 67.395 101.380 90.00 90.00 90.00 P 43 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014838 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014838 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009864 0.00000